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Abstract
Background: Acanthamoeba species are the causative agents of fatal granulomatous encephalitis in humans.
Haematogenous spread is thought to be a primary step, followed by blood–brain barrier penetration, in the
transmission of Acanthmaoeba into the central nervous system, but the associated molecular mechanisms remain
unclear. Here, we evaluated the role of Src, a non-receptor protein tyrosine kinase in the biology and pathogenesis
of Acanthamoeba.
Methods: Amoebistatic and amoebicidal assays were performed by incubating amoeba in the presence of Src
kinase-selective inhibitor, PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) and its inactive
analog, PP3 (4-amino-7-phenylpyrazolo[3,4-d]pyrimidine). Using this inhibitor, the role of Src kinase in A. castellanii
interactions with Escherichia coli was determined. Zymographic assays were performed to study effects of Src kinase
on extracellular proteolytic activities of A. castellanii. The human brain microvascular endothelial cells were used to
determine the effects of Src kinase on A. castellanii adhesion to and cytotoxicity of host cells.
Results: Inhibition of Src kinase using a specific inhibitor, PP2 (4-amino-5-(4 chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d]
pyrimidine) but not its inactive analog, PP3 (4-amino-7-phenylpyrazolo[3,4-d] pyrimidine), had detrimental effects on
the growth of A. castellanii (keratitis isolate, belonging to the T4 genotype). Interestingly, inhibition of Src kinase
hampered the phagocytic ability of A. castellanii, as measured by the uptake of non-invasive bacteria, but, on the
contrary, invasion by pathogenic bacteria was enhanced. Zymographic assays revealed that inhibition of Src kinases
reduced extracellular protease activities of A. castellanii. Src kinase inhibition had no significant effect on A.
castellanii binding to and cytotoxicity of primary human brain microvascular endothelial cells, which constitute the
blood–brain barrier.
Conclusions: For the first time, these findings demonstrated that Src kinase is involved in A. castellanii proliferation,
protease secretions and phagocytic properties. Conversely, invasion of Acanthamoeba by pathogenic bacteria was
stimulated by Src kinase inhibition.
Keywords: Acanthamoeba, Pathogenesis, Encephalitis, Src kinase

Background
Based on the ribosomal DNA (rDNA) sequencing, the
genus Acanthamoeba represents 17 different groups, i.e.,
T1 – T17 [1-3]. The basis of this scheme is that each
group (or genotype) exhibits ≥ 5% rDNA sequence divergence from other genotypes. Pathogenic Acanthamoeba
(predominantly belonging to the T4 genotype) can produce painful, blinding keratitis, normally associated with
contact lens use or a fatal granulomatous amoebic
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encephalitis (GAE), primarily associated with immunocompromised patients [4-6]. The most distressing aspect
is that the prognosis is poor, despite advances in
antimicrobial chemotherapy and supportive care. In
particular, there is very limited success in the treatment
of GAE, which is most likely due to the inability of drugs
to cross the blood–brain barrier into the central nervous
system (CNS) to target pathogen, non-specific toxicity,
and amoebae transformation into resistant cyst forms.
However, alkylphosphocholine compounds show promise [7]. Among them, hexadecylphosphocholine has been
shown to possess anti-Acanthamoeba characteristics and
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has the ability to cross the blood–brain barrier. To date,
their mode of action and in vivo efficacy are unknown.
Clearly, there is a need to find novel strategies in the rational development of therapeutic interventions.
The burden of Acanthamoeba keratitis on human
health is estimated at 0.01 – 1.5 infections per 10,000
people who wear contact lens [4]. In contrast, a true or
even approximate burden of encephalitis on human
health is not known. As indicated above, GAE infections
are usually limited to immunocompromised patients,
such as those with HIV/AIDS [8]. GAE can also occur in
chronically ill or debilitated individuals, some of whom
take immunosuppressive therapy or broad-spectrum
antibiotics [8]. The pathogenesis of the disease is not
clearly understood, although the route of infection is
thought to relate to the inhalation of the amoebae
through the nasal passages and lungs or infection
through skin lesions [8]. The respiratory and cutaneous
infections tend to last for a few months, whereas infection involving the CNS can be fatal within days [5,6].
The haematogenous spread by circulating amoebae is a
prerequisite for GAE, followed by their traversal of the
blood–brain barrier, but the underlying mechanisms remain incompletely understood [4,9]. It is possible that
new targets may be found in the signal transduction
pathways that can affect amoeba survival and hostpathogen interactions. Src is a member of a larger family
of related tyrosine kinases that includes Fyn, Yes, Lck,
Blk, Lyn, Hck, Yrk and Fgr. Src is a non-receptor protein
tyrosine kinase and its activation is mainly regulated by
phosphorylation at the tyrosine 416 residue [10]. Src signalling has been implicated in a variety of cellular processes, including cell growth, survival, cellular
transformation and motility [11,12]. For the first time, in
the present study, we investigated the role of Src kinase
in A. castellanii.

Methods
All chemicals were purchased from Sigma (Poole, Dorset, UK), unless otherwise stated.

Culturing of Acanthamoeba castellanii

An A. castellanii isolate belonging to the T4 genotype
was obtained from the American Type Culture Collection (ATCC50492), and sourced from a keratitis patient.
The cells were grown axenically in 10 ml of PYG
medium [0.75% (w/v) proteose peptone, 0.75% (w/v)
yeast extract and 1.5% (w/v) glucose] (Oxoid Ltd.,
Basingstoke, UK) in a T-75 tissue culture flask at 30 °C
as previously described [13]. The medium was refreshed
17 – 20 h prior to experiments, which resulted in > 95%
of amoebae in the trophozoite form.
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Human brain microvascular endothelial cell (HBMEC)
culture

The primary BMEC were isolated from the human tissue
and purified by fluorescent activated cell sorting (FACS)
and exhibited endothelial characteristics, such as expression of endothelial markers, F-VIII, carbonic anhydrase
IV and uptake of acetylated low density lipoprotein
(AcLDL) as previously described [13,14]. HBMEC were
grown in RPMI-1640 containing 10% foetal bovine
serum, 10% NuSerum, 2 mM glutamine, 1 mM pyruvate,
penicillin (100U/ml), streptomycin (100U/ml), nonessential amino acids and vitamins (Invitrogen, Paisley,
UK) [13,14].
Amoebistatic and amoebicidal assays

A. castellanii were grown to confluency in 24-well
plates. Next day, plates were washed with PBS to remove
unbound amoebae. The varying concentrations of a potent, Src kinase-selective inhibitor, PP2 (4-amino-5-(4chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) [15]
and its inactive analog, PP3 (4-amino-7-phenylpyrazolo
[3,4-d]pyrimidine) [16] (Calbiochem, San Diego, CA,
USA) were added. For growth assays, amoebae plus inhibitors were incubated in PYG medium for various intervals of time, followed by haemocytometer counting. For
viability assays, amoeba plus inhibitors were incubated
in PBS for 24 h, and viability determined by Trypan blue
exclusion testing using haemocytometer counting [17].
For controls, normal growth rates of A. castellanii were
determined using growth medium alone, i.e., PYG or
amoebae incubated in PBS in the absence of inhibitors.
Zymographic assays

The extracellular proteolytic activities of Acanthamoeba
were determined using zymographic assays as previously
described [18]. Briefly, A. castellanii were incubated in the
presence or absence of various concentrations of Src kinase inhibitors for 24 h. Next day, cell-free supernatants
(CM, conditioned medium) were collected by centrifugation. The CM were electrophoresed on sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
containing gelatin (2 mg/ml) as a protease substrate. After
electrophoresis, gels were washed in 2.5% Triton X-100
(wt/vol) for 60 min, then incubated in developing buffer
(50 mM Tris–HCl, pH 7.5, containing 10 mM CaCl2) at
37 °C overnight. Next day, gels were stained with Coomassie Brilliant Blue. Areas of gelatin digestion were visualised
as non-staining regions in the gel.
Phagocytosis assays using live, non-invasive E. coli K-12

A. castellanii were grown to confluency in 24-well
plates. Next day, plates were washed with PBS to remove
unbound amoebae. A. castellanii were incubated with
various concentrations of Src kinase inhibitor, PP2 and

Siddiqui et al. Parasites & Vectors 2012, 5:112
http://www.parasitesandvectors.com/content/5/1/112

its inactive analog, PP3 in RPMI at room temperature
for 30 min. After this incubation, A. castellanii were
washed with PBS to remove any residual inhibitor. Next,
live Escherichia coli K-12 (107/well), a non-invasive laboratory strain, HB101 were added and plates were incubated for 45 min to allow phagocytic uptake. Following
this incubation, supernatants were removed and gentamicin was added (final conc. 100 μg/ml for 45 min) to
kill any remaining extracellular E. coli. Next, the numbers of A. castellanii were determined using haemocytometer counting. Finally, A. castellanii were solubilized
with 0.5% SDS and E. coli counts were determined by inoculating lysates on nutrient agar plates. This allowed
the determination of any intracellular E. coli.
Determination of relative phagocytic activity

The level of A. castellanii phagocytosis was determined
as follows: No. of E. coli colony forming units (cfu)/Total
number of A. castellanii x 100 = % phagocytosis. Results
are expressed as relative phagocytosis (% phagocytosis in
untreated A. castellanii was considered as 100% and
levels of phagocytosis in inhibitor-treated A. castellanii
are shown as percentage change).
Invasion assays using live pathogenic E. coli K1

Invasion assays were performed as for phagocytosis assays
except that an invasive strain of E. coli K1, RS218 (O18:K1:
H7) a cerebrospinal fluid isolate from a meningitis patient)
was used as opposed to the non-invasive K-12.
Adhesion assays

To determine the ability of A. castellanii to bind
HBMEC, adhesion assays were performed [19]. Briefly,
HBMEC were grown to confluency in 24-well plates. A.
castellanii (4 x 105 amoebae/well) were pre-incubated
with various concentrations of inhibitor for 30 min.
After this incubation, A. castellanii were washed with
PBS to remove residual inhibitor. Finally, A. castellanii
were added to HBMEC monolayers in RPMI 1640 containing 2 mM glutamine, 1 mM pyruvate and nonessential amino acids) and plates incubated at 37 °C in a
5% CO2 incubator. After 1 h incubation, the unbound
amoebae were counted using a haemocytometer and the
numbers of bound amoebae were calculated as follows:
No. of unbound amoebae/Total number of amoebae x
100 = % unbound amoebae. The numbers of bound
amoebae were deduced as follows: % unbound amoebae
– 100 = % bound amoebae.
Cytotoxicity assays

Cytotoxicity assays were performed as previously
described [19]. Briefly, A. castellanii were pre-treated with
PP2 and PP3 and incubated with HBMEC monolayers
grown in 24-well plates as described for adhesion assays.
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Plates were incubated at 37 °C in a 5% CO2 incubator and
periodically observed for cytopathic effects for up to 24 h.
At the end of this incubation period, supernatants were
collected and cytotoxicity was determined by measuring
lactate dehydrogenase (LDH) release (cytotoxicity detection kit; Roche Applied Science, Lewes, East Sussex, UK).
Briefly, conditioned media of co-cultures of A. castellanii
and HBMEC were collected and percentage LDH was
detected as follows: (sample value – control value/total
LDH release – control value x 100 = % cytotoxicity). Control values were obtained from HBMEC incubated in
RPMI alone. Total LDH release was determined from
HBMEC treated with 1% Triton X-100 for 30 min at 37 °C.
Acanthamoeba Src kinase identification and sequence
alignments

Putative Acanthamoeba Src kinase protein was searched
in Acanthamoeba castellanii genome database, hosted
by The Human Genome Sequencing Center, Baylor College of Medicine (http://blast.hgsc.bcm.tmc.edu/blast.
hgsc?organism = AcastellaniNeff ), using closely related
Monosiga brevicollis Src1 kinase protein sequence (NCBI
accession No. AAP78682) [20], through BLAST search.
Recovered Acanthamoeba protein was further aligned
with its different homologs in other organisms using
MUSCLE 3.8 hosted at European Bioinformatics Institute webpage (http://www.ebi.ac.uk/Tools/msa/muscle/).
The name and NCBI accession numbers of different organisms Src kinase proteins used in alignment, are Drosophila
melanogaster c-Src (AAA28913.1), Caenorhabditis elegans
Src1 (NP_490866), Ephydatia fluviatilis Src related protein
(BAB83688), Monosiga brevicollis Src1 (EDR48627.1) Hydra
vulgaris (AAA29217.1) and Human cSrc (NP_005408).

Results and discussion
Inhibition of src kinase reduced A. castellanii growth

To determine the role of Src kinase on the biological properties of A. castellanii, growth and viability assays were performed. Growth under control conditions (amoebae
incubated in growth medium in the absence of inhibitor)
showed an approximate doubling of the number of cells
every 24 h (Figure 1). However, the presence of Src kinase
inhibitor, PP2, significantly reduced growth [P = 0.015 for
amoebae in PYG versus amoebae in PYG plus PP2 (50 μM)
at 96 h, using T-test, paired, one tail distribution] but did
not affect amoebic viability, as determined by Trypan blue
exclusion test (0% effects). At micromolar concentrations
of PP2 (50 μM), amoeba growth was abolished. In contrast,
inactive analog Src kinase, PP3 affected neither growth nor
viability of A. castellanii for any time point tested [P = 0.051
for amoebae in PYG versus amoebae in PYG plus PP3
(50 μM) at 96 h, using T-test, paired, one tail distribution]
(Figure 1).
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Figure 1 Src kinase inhibitor, PP2 exhibited amoebistatic
effects. A. castellanii were incubated in the presence of Src kinasespecific inhibitor, PP2 or its inactive analog, PP3 in normal growth
medium (PYG) for various intervals of time. Cell numbers were
determined using haemocytometer counting. Micromolar
concentrations of PP2 but not PP3 abolished amoebae growth.
Results represent the mean of three independent experiments
performed in duplicate, bars represent standard error.

Src kinase inhibition blocked A. castellanii phagocytosis in
a concentration-dependent manner

To determine the effects of Src kinases on A. castellanii
phagocytosis of E. coli K-12, phagocytosis assays were
performed. It was observed that A. castellanii exhibited
significant reduced bacterial uptake in the presence of
PP2, specific Src kinase inhibitor [P = 0.038 for amoebae
with K-12 versus amoebae with K-12 plus PP2 (50 μM),
using T-test, paired, one tail distribution], although there
was no difference at 10 μM (P = 0.21) (Figure 2). At 100
μM of PP2, more than 50% inhibition of A. castellanii
uptake of E. coli K-12 strain, HB101 was observed
(Figure 2). In contrast, PP3, an inactive analog of PP2,
had no effect on bacterial uptake by A. castellanii at any
of the concentrations tested (P = 0.127 for amoebae with
K-12 versus amoebae with K-12 plus PP3 (50 μM), using
T-test, paired, one tail distribution) (Figure 2).
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Figure 2 Inhibition of Src kinase blocks A. castellanii
phagocytosis. The effects of Src kinase in the ability of A. castellanii
to uptake live non-invasive E. coli strain, HB101. Untreated A.
castellanii were used as 100% phagocytosis and levels of
phagocytosis in inhibitor-treated A. castellanii are shown as
percentage change. Note that Src kinase inhibitor, PP2 but not its
inactive analog, PP3 exhibits a significant decrease in A. castellanii
phagocytosis at 50 μM (P < 0.05). Results represent the mean of
three independent experiments performed in duplicate, bars
represent standard error.

PP3 (50 μM), using T-test, paired, one tail distribution]
(Figure 3).
Src kinases are involved in Acanthamoeba protease
secretions

To determine the role of Src kinase in A. castellanii protease secretion, conditioned medium (CM) was produced in the presence of Src kinase inhibitor, PP2, or its
inactive analog, PP3 and analysed for protease activities.

Pathogenic E. coli K1 invasion of A. castellanii was
enhanced using Src kinase inhibitor, PP2

In contrast to phagocytic uptake of non-invasive bacteria
by Acanthamoeba (Figure 2), effects of Src kinase were
reversed in the invasion of pathogenic E. coli K1 into A.
castellanii. Pre-treatment of A. castellanii with PP2 significantly enhanced invasion of pathogenic bacteria
[P = 0.026 for amoebae with K-12 versus amoebae with
K-12 plus PP2 (50 μM), using T-test, paired, one tail distribution], although there was no difference at 10 μM
(P = 0.077) (Figure 3). At 100 μM of PP2, invasion of a
neuropathogenic E. coli K1 into A. castellanii was more
than doubled (Figure 3). In contrast, PP3, an inactive
analog of PP2 had no effect on bacterial uptake by A.
castellanii at any of the concentrations tested [P = 0.09
for amoebae with K-12 versus amoebae with K-12 plus

Figure 3 Src kinase inhibition enhanced neuropathogenic E.
coli K1 invasion of A. castellanii. The involvement of Src kinase in
the invasion of pathogenic E. coli (meningitis isolate) into A.
castellanii was determined. Untreated A. castellanii were used as
100% phagocytosis and levels of bacterial invasion in inhibitortreated A. castellanii are shown as percentage change. Src kinase
inhibitor, PP2 but not its inactive analog, PP3 exhibits a significant
increase in bacterial invasion of A. castellanii (P < 0.05). Results
represent the mean of three independent experiments performed in
duplicate, bars represent standard error of the mean.
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In the absence of any inhibitor, A. castellanii exhibited
significant proteolytic activities (Figure 4). The proteolytic activity was sensitive to phenylmethylsulfonyl fluoride (PMSF), a serine protease inhibitor, indicating
specific inhibition (data not shown). In contrast, CM
prepared in the presence of PP2 exhibited reduced protease activities (> 50% inhibition) (Figure 4), while PP3
exhibited no effects (Figure 4). The protease secretion
was increasingly reduced with a corresponding increase
in the concentration of PP2, an effect not observed when
PP3 was used (Figure 4).
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paired, one tail distribution). Next, to determine the
effects of PP2 on A. castellanii-mediated HBMEC death,
cytotoxicity assays were performed. In the absence of
PP2, Acanthamoeba produced severe HBMEC cell cytotoxicity (up to 65%) within 24 h (Figure 5B). Although
A. castellanii pre-treatment with PP2 showed increased
HBMEC cytotoxicity due to amoebae, however, these
effects were insignificant (At 100 μM of PP2, P = 0.053,
using T-test, paired, one tail distribution) (Figure 5B). In
contrast, PP3 had no effects on A. castellanii-mediated
HBMEC cytotoxicity (At 100 μM of PP3, P = 0.10, using
T-test, paired, one tail distribution) (Figure 5B).

Src kinases did not affect Acanthamoeba adhesion to and
cytotoxicity of HBMEC

To determine the involvement of Src kinase in A. castellanii binding to and cytotoxicity of HBMEC, assays were
performed. It was observed that neither PP2 nor PP3
had any significant effect on Acanthamoeba binding to
HBMEC monolayers (Figure 5A) (At 100 μM, P = 0.086
for PP2 and P = 0.256 for PP3 respectively, using T-test,

Figure 4 Representative effects of Src kinase inhibitor on
extracellular proteases of Acanthamoeba. (A) A. castellanii were
incubated in RPMI in the presence or absence of PP2 or PP3.
Conditioned medium (CM) was collected and proteolytic activities
determined using zymographic assays. Note that PP2, a specific Src
kinase inhibitor blocked A. castellanii proteases. Results are
representative of three independent experiments. (B) The density of
the bands was quantitated using an imaging densitometer. Data
represent the mean of three independent experiments, bars
represent standard error.

Figure 5 Inhibition of Src kinase had no effect on A. castellanii
adhesion to and cytotoxicity of HBMEC. (A) Various
concentrations of PP2 or PP3 were added to A. castellanii (4 x 105
amoebae/well) for 30 min. After this incubation, A. castellanii were
washed with PBS, and added to HBMEC monolayers for 1 h. The
unbound amoebae were counted using a haemocytometer and the
numbers of bound amoebae were deduced as follows: No. of
unbound amoebae/Total number of amoebae x 100 = % unbound
amoebae. The numbers of bound amoebae were deduced as
follows: % unbound amoebae – 100 = % bound amoebae. (B) As for
adhesion assays, amoebae were incubated with HBMEC for up to
24 h and the percent HBMEC cytotoxicity was determined by
measuring LDH release. Results represent the mean of three
independent experiments performed in duplicate. Bars represent
standard error.
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Acanthamoeba src kinase identification and sequence
alignments

A BLAST search of Monosiga brevicollis Src1 protein in
the A. castellanii genome resulted in the identification
of protein (of 639 amino acids in length), which was
found to be similar in architecture to human cSrc and
its orthologs (Figure 6a and b), indicated here as Acanthamoeba castellanii Src kinase (AcSrc). Putative AcSrc
kinase shares considerable amino acid homology with its
orthologs [36% with Caenorhabditis elegans Src1
(NP_490866); 34% with Ephydatia fluviatilis Src related
protein (BAB83688); 33% with Hydra vulgaris
(AAA29217.1); 31% with Drosophila melanogaster c-Src
(AAA28913.1)]. However, it also has its unique N- and
C-terminal regions which are not homologous to its
orthologs but to a small hypothetical protein of the fungus Verticillium dahliae in NCBI database (data not
shown). In the human cSrc kinases protein, phosphorylation of tyrosine at positions 419 and 530 (Y419 and
Y530) marks the protein for active and inactive state, respectively [21,22]. Of these two phosphorylation sites, a
tyrosine residue corresponding to Y530 of human cSrc
is present in AcSrc kinase, but the tyrosine residue corresponding to Y419 of human cSrc is absent. This information suggests that the AcSrc kinase might be
constitutively active in Acanthamoeba. The role of these
conserved tyrosine residue Y530 is not clear in protist
Src kinases, because the phosphorylation of MbSrc1 in
Monosiga brevicolli at the tyrosine residue corresponding to Y530 of human cSrc kinase did not result in an
inactivation of its kinase activity, unlike its human
homologs [20], which may explain the functioning of
AcSrc. The amino acids which take part in binding of
ATP and PP2 in human Srk kinases [23,24] showed
similarity in AcSrc (Figure 6b). This further supported
our findings that PP2 binds and inhibits Acanthamoeba
Src kinase, which might have a role in important cellular
processes, such as growth and phagocytosis.
Recent studies have shown that Acanthamoeba exhibits multifactorial virulence properties to produce damage of HBMEC, which constitute the blood–brain
barrier, to produce encephalitis and corneal epithelial
cells to induce keratitis [4]. Here, we studied the role of
Src kinases on the biology and pathogenesis of Acanthamoeba. The findings revealed that Src kinase inhibitor,
PP2, but not its inactive analog, PP3, abolished A. castellanii proliferation. These findings indicate that Src
kinases have a pivotal role in the growth of A. castellanii, which is consistent with some previous findings that
showed that Src is an important signalling molecule
involved in the growth of various eukaryotic cell types
[11,12]. Src kinases act on a number of substrates in the
cell, including enzymes involved in phospholipid metabolism, such as the p85 subunit of PI3-K, phopholipase
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C-γ (PLC-γ) and the signalling molecules p190RhoGAP,
p120rasGAP and EGF receptor substrate, Eps8, involved
in cellular transformation, proliferation and survival [2527]. Phospholipid metabolism is important for the synthesis and maintenance of the cell membrane. Inhibition
of this pathway would result in a cessation of growth
and proliferation, a possible explanation for the present
findings relating to the transformation of amoebae into
the cyst form. The fact that Src kinases are involved in
the life cycle and growth of A. castellanii suggest that
they should be studied further.
A. castellanii use phagocytosis for food uptake (such
as non-invasive E. coli K-12), whereas E. coli K1 (a
causative agent of bacterial meningitis), utilises A. castellanii as a reservoir and invades into the Acanthamoeba.
Inhibition of Src kinase reduced A. castellanii phagocytosis of non-invasive K-12 with an increase in the concentration of PP2, while opposite effects were observed
for invasive E. coli K1. A likely explanation is that E. coli
K-12 is a food source for amoebae. In such situations,
the process of bacterial uptake is most likely to be
“driven” by A. castellanii, which would be dependent on
amoeba intracellular signal transduction pathways involving Src kinases. In contrast, neuropathogenic E. coli
K1 is an invasive strain. Their invasion of A. castellanii
is most likely reliant on bacterial invasion, which might
explain the involuntary uptake of E. coli K1 by A. castellanii, as observed in the present study. However, this
contrasts with results of previous studies [16,28,29],
which showed the involvement of Src in Staphylococcus
aureus-invasion of embryonic kidney cells, Shigella invasion of epithelial cells and uropathogenic E. coli-invasion
of bladder epithelial cells, which may be due to different
host cell types, i.e., phagocytic Acanthamoeba versus
non-phagocytic host cells. Future studies are needed to
address these aspects in a comparative way.
Acanthamoeba are known to secrete large amounts of
proteases that are shown to be key virulence factors in
keratitis [30,31] as well as GAE infections [9,13]. For example, it is shown that serine proteases of Acanthamoeba increased the permeability of the blood–brain
barrier by over 45% [32], while intrastromal injection of
amoeba excretory products produced lesions similar to
those observed in keratitis patients [31]. In the present
study, it was observed that Src kinase played an important role in the protease secretion by A. castellanii. The
proteases involved were shown to be serine proteases,
inhibited by PMSF. This is significant as the inhibition
of serine proteases dramatically reduce the ability of A.
castellanii to cause inflammation and tissue damage
[13,32] and possibly subsequent GAE.
Previous studies have shown that the adhesion of A.
castellanii to the host cell is an important step in the
pathogenesis of acanthamoebiasis [33,34]. Our findings
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Figure 6 Sequence alignment of Acanthamoeba castellanii Src kinase and its orthologs. (a) Domain architecture of human c-Src kinase. The
two important regulatory phosphorylation sites (Y419 and Y530) are marked. (b) Putative Acanthamoeba Src kinase (AcSrc) sequence was aligned
with Drosophila melanogaster c-Src (DmSrc), Caenorhabditis elegans Src (CeSrc), Ephydatia fluviatilis Src related protein (EfSrc), Monosiga brevicollis
Src1 (MbSrc), Hydra vulgaris (HvSrc) and Homo sapiens cSrc (HsSrc). The SH3, SH2 and catalytic domain are indicated with yellow, blue and green
bars above the sequence, respectively. Asterisk (*), colon (:) and period (.) marks the region of conserved, strongly similar and weakly similar
residues, respectively. Whereas black diamond represents residues involve in ATP binding; black arrowheads represents residues form hydrogen
bond with PP2, and black circles indicates the Y419 and Y530 phosphorylation sites in human cSrc, most of which are also conserved in AcSrc.

revealed that Src kinase had a minimal effect on A. castellanii adhesion to HBMEC, which is not surprising, as
Src kinases are regulators of intracellular signalling pathways, and the binding of amoebae to HBMEC is known
to be mediated by mannose-binding protein expressed
on the surface membranes of Acanthamoeba [33,34].
Given that Src kinases inhibited protease secretion and
phagocytic activity of A. castellanii and that both properties have been implicated in the pathogenicity of
Acanthamoeba, it was anticipated that inhibition of Src
kinases would result in reduced A. castellanii-mediated
HBMEC cytotoxicity. It was surprising that the inhibition of Src kinases had no significant effect on HBMEC
cytotoxicity. However, cytotoxicity is a delayed event and
PP2 effects are reversible [19]. The fact that assays were
performed by pre-treatment of A. castellanii with PP2
for 30 min followed by their incubation with HBMEC
for 24 h. in the absence of inhibitor, may explain these
findings. As PP2 has toxic effects on the host cells,
assays could not be performed in the presence of PP2
for longer periods of time. Future studies, using host
cells expressing dominant negative forms of Src kinases,
should establish their involvement in A. castellaniimediated HBMEC cytotoxicity.

Conclusions
For the first time, the present findings showed that Src
kinases are involved in the proliferation, phagocytic
properties and proteolytic activities of A. castellanii. Future studies should further explore the precise mechanisms associated with Acanthamoeba pathogenesis, which
may help develop preventative and/or therapeutic interventions against acanthamoebiasis.
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